Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) ROCE %: 12.37% (As of Mar. 2026)


NSE:MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
80 GF Score
Price ₹187.00
GF Value ₹228.09
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vaidyane Ayurved Laboratories ROCE %?

Vaidyane Ayurved Laboratories NSE:MADHAVBAUG +2.05% 80 ROCE % is 12.37% as of Mar. 2026. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 80/100 and a GF Value™ of ₹228.09 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vaidyane Ayurved Laboratories's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.37%.

Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vaidyane Ayurved Laboratories ROCE % Related Terms

Vaidyane Ayurved Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Vaidyane Ayurved Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaidyane Ayurved Laboratories ROCE % Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 20.07 16.66 6.22 17.39 14.67

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.82 16.25 18.75 19.27 12.37
NSE:MADHAVBAUG
80GF Score
Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaidyane Ayurved Laboratories ROCE % Calculation

Vaidyane Ayurved Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=116.555/( ( (767.094 - 112.245) + (1045.072 - 111.109) )/ 2 )
=116.555/( (654.849+933.963)/ 2 )
=116.555/794.406
=14.67 %

Vaidyane Ayurved Laboratories's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=101.678/( ( (820.116 - 110.563) + (1045.072 - 111.109) )/ 2 )
=101.678/( ( 709.553 + 933.963 )/ 2 )
=101.678/821.758
=12.37 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.37% mean?
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a ROCE % of 12.37% as of Mar. 2026.
Is Vaidyane Ayurved Laboratories' ROCE % too high?
Vaidyane Ayurved Laboratories' current ROCE % is 12.37%. The Drug Manufacturers industry median ROCE % is 7.03. Vaidyane Ayurved Laboratories' value of 12.37% is 76% above this industry median. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' ROCE % compare to ZTS and UTHR?
Vaidyane Ayurved Laboratories' ROCE % of 12.37% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Vaidyane Ayurved Laboratories' value of 12.37% is 76% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaidyane Ayurved Laboratories's current ROCE % of 12.37% is 76% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current ROCE % is 12.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.09, compared to a current price of ₹187.00 — trading 18% below its estimated fair value. The current ROCE % is 12.37% and 76% above the Drug Manufacturers industry median of 7.03. Vaidyane Ayurved Laboratories' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current ROCE % is 12.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?

Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued. The current stock price of ₹187.00 is trading 18% below its estimated GF Value™ of ₹228.09. GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:MADHAVBAUG:

  • ROCE %: 12.37%
  • GF Value™: ₹228.09 vs. price of ₹187.00 (18% below fair value)
  • GF Score™: 80/100 with 4 warning signs
  • Industry Position: 76% above the Drug Manufacturers median

No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaidyane Ayurved Laboratories Business Description

Address 201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
80GF Score

Get the complete analysis for NSE:MADHAVBAUG

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹187.00
Price
₹228.09
GF Value